Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort

被引：0
作者：
Edouard Auclin
Lysiane Marthey
Raef Abdallah
Léo Mas
Eric Francois
Angélique Saint
Antonio Sa Cunha
Angélique Vienot
Thierry Lecomte
Vincent Hautefeuille
Christelle de La Fouchardière
Matthieu Sarabi
Feryel Ksontini
Julien Forestier
Romain Coriat
Emmanuelle Fabiano
Florence Leroy
Nicolas Williet
Jean-Baptiste Bachet
David Tougeron
Julien Taieb
机构：
[1] Université de Paris,Department of Hepato
[2] Paris Descartes University,Gastroenterology and Gastrointestinal Oncology
[3] Hôpital Européen Georges Pompidou,Department of Medical and Thoracic Oncology
[4] Université de Paris,Department of Gastroenterology
[5] Hôpital Européen Georges Pompidou,Department of Gastroenterology
[6] Kremlin Bicêtre Hospital,Department of Oncology
[7] Assistance Publique-Hôpitaux de Paris (AP-HP),Department of Digestive Surgery
[8] Paris Sud University,Department of Oncology
[9] La Pitié-Salpêtrière Hospital,Department of Hepato
[10] Assistance Publique-Hôpitaux de Paris (AP-HP),Gastroenterology and Digestive Oncology
[11] Anticancer Center A Lacassagne,Department of Gastroenterology and Digestive Oncology
[12] Hôpital Paul Brousse,Department of Gastrointestinal Oncology
[13] Besançon University Hospital,Department of Oncology
[14] University Hospital Trousseau,Department of Gastroenterology
[15] Amiens University Hospital,Department of Gastroenterology
[16] Centre Léon Bérard,Department of Radiotherapy
[17] Institute Salah-Azaïz,Department of GI Oncology
[18] Hôpital Edouard Herriot,Department of Gastroenterology
[19] Hôpital Cochin,Department of Hepato
[20] Assistance Publique-Hôpitaux de Paris (AP-HP),Gastroenterology
[21] Université de Paris,undefined
[22] Hôpital Européen Georges Pompidou,undefined
[23] Institut Gustave Roussy,undefined
[24] University Hospital of Saint-Etienne,undefined
[25] Poitiers University Hospital,undefined
[26] University of Poitiers,undefined
来源：
British Journal of Cancer | 2021年 / 124卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1941 / 1948
页数：7
相关论文
共 135 条
  • [1] Siegel RL(2018)Cancer statistics, 2018 CA Cancer J. Clin. 68 7-30
  • [2] Miller KD(2010)Advanced pancreatic carcinoma: current treatment and future challenges Nat. Rev. Clin. Oncol. 7 163-172
  • [3] Jemal A(2015)Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann. Oncol. 26 v56-v68
  • [4] Stathis A(2013)Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design Ann. Surg. Oncol. 20 2787-2795
  • [5] Moore MJ(2019)Pancreatic Adenocarcinoma, Version 1.2019 J. Natl Compr. Cancer Netw. 17 202-210
  • [6] Ducreux M(2017)Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial Lancet 389 1011-1024
  • [7] Cuhna AS(2016)FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis Lancet Oncol. 17 801-810
  • [8] Caramella C(2008)Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study Ann. Oncol. 19 1592-1599
  • [9] Hollebecque A(2015)FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies Pancreas 44 515-521
  • [10] Burtin P(2011)FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N. Engl. J. Med. 364 1817-1825
12345678910